Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer
- Lampropoulou, Dimitra-Ioanna 1
- Aravantinos, Gerasimos 1
- Katifelis, Hector 3
- Lazaris, Foivos 34
- Laschos, Konstantinos 1
- Theodosopoulos, Theodosios 2
- Papadimitriou, Christos 2
- Gazouli, Maria 3
- 1 Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece
- 2 Second Department of Surgery, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
- 3 Laboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
-
4
Universidad de La Rioja
info
ISSN: 1875-8592, 1574-0153
Año de publicación: 2019
Volumen: 25
Número: 2
Páginas: 213-221
Tipo: Artículo
Otras publicaciones en: Cancer Biomarkers
Referencias bibliográficas
- Favoriti, (2016), Updates in Surgery, 68, pp. 7, 10.1007/s13304-016-0359-y
- Hammond, (2016), Therapeutic Advances in Medical Oncology, 8, pp. 57, 10.1177/1758834015614530
- Emani, (2017), Asian Pacific Journal of Cancer Prevention, 18, pp. 2803
- Hon, (2018), Frontiers in Pharmacology, 9, pp. 1, 10.3389/fphar.2018.00846
- Pan, (2015), Asian Pacific Journal of Cancer Prevention, 16, pp. 8067, 10.7314/APJCP.2015.16.18.8067
- Zhou, (2014), Acta Biochimica Et Biophysica Sinica, 46, pp. 1011, 10.1093/abbs/gmu104
- Li, (2017), Cellular Physiology and Biochemistry, 42, pp. 1192, 10.1159/000478917
- Gong, (2017), Acta Pharmacologica Sinica, 38, pp. 581, 10.1038/aps.2016.164
- Tang, (2018), Cellular Physiology and Biochemistry, 47, pp. 893, 10.1159/000490131
- Min, (2018), OncoTargets and Therapy, 14, pp. 791, 10.2147/OTT.S151454
- Hajjari, (2015), Cancer Biology and Medicine, 12(1, pp. 1
- Tian, (2016), PLoS One, 11, pp. e0152296, 10.1371/journal.pone.0152296
- Özdemir, (2017), Trends in Cancer, 3, pp. 181, 10.1016/j.trecan.2017.02.002
- Luo, (2016), World of Journal Gastroenterology, 22, pp. 5252, 10.3748/wjg.v22.i22.5254
- Liu, (2013), PLoS One, 8, pp. e77293, 10.1371/journal.pone.0077293
- Yang, (2018), Biochemical and Biophysical Research Communications, 497, pp. 1003, 10.1016/j.bbrc.2018.02.141
- Wang, (2017), Hematology, 22, pp. 208, 10.1080/10245332.2016.1258152
- Amodio, (2018), Journal of Hematology & Oncology, pp. 63, 10.1186/s13045-018-0606-4
- Li, (2017), Oncotarget, 8, pp. 92604, 10.18632/oncotarget.21507
- Fang, (2018), Biomedicine and Pharmacotherapy, 101, pp. 536, 10.1016/j.biopha.2018.02.130
- Long, (2017), Molecular Cancer, 16, pp. 167, 10.1186/s12943-017-0723-7
- Lu, (2017), Oncology Letters, 13, pp. 1131, 10.3892/ol.2016.5544
- Li, (2017), Molecular Cancer Therapeutics, 16, pp. 739, 10.1158/1535-7163.MCT-16-0591
- Ratain, (2002), Journal of Clinical Oncology, 20, pp. 7, 10.1200/JCO.2002.20.1.7
- Glimelius, (2005), Drug Safety, 28, pp. 417, 10.2165/00002018-200528050-00005
- Fujita, (2015), World Journal of Gastroenterology, 21, pp. 12234, 10.3748/wjg.v21.i43.12234
- Toffoli, (2006), Journal of Clinical Oncology, 24, pp. 3061, 10.1200/JCO.2005.05.5400
- Van Cutsem, (2016), Annals of Oncology, 27, pp. 1386, 10.1093/annonc/mdw235
- Fuchs, (2007), Journal of Clinical Oncology, 25, pp. 4779, 10.1200/JCO.2007.11.3357
- Shui, (2018), Cellular Physiology and Biochemistry, 48, pp. 1870, 10.1159/000492508
- Saltz, (2008), Journal of Clinical Oncology, 26, pp. 2013, 10.1200/JCO.2007.14.9930
- Van Cutsem, (2009), The New England Journal of Medicine, 360, pp. 1408, 10.1056/NEJMoa0805019
- Van Cutsem, (2011), Journal of Clinical Oncology, 29, pp. 2011, 10.1200/JCO.2010.33.5091
- Ciardiello, (2014), Journal of Clinical Oncology, 32, pp. LBA443, 10.1200/jco.2014.32.3_suppl.lba443
- Seymoyr, (2013), Lancet Oncology, 14, pp. 749, 10.1016/S1470-2045(13)70163-3
- Eisenhauer, (2009), European Journal of Cancer, 45, pp. 228, 10.1016/j.ejca.2008.10.026
- Hatzaki, (2001), Molecular and Cellular Probes, 15, pp. 243, 10.1006/mcpr.2001.0367
- Ding, (2015), Tumour Biology, 36, pp. 3361, 10.1007/s13277-014-2970-1
- Skof, (2009), BMC Cancer, 9, pp. 120, 10.1186/1471-2407-9-120
- Goldberg, (2004), Journal of Clinical Oncology, 22, pp. 23, 10.1200/JCO.2004.09.046
- Leonard, (2002), British Journal of Cancer, 87, pp. 1216, 10.1038/sj.bjc.6600641
- Cheng, (2014), Cancer Chemotherapy Pharmacology, 73, pp. 551, 10.1007/s00280-014-2382-3
- Wang, (2012), World Journal of Gastroenterology, 18, pp. 6635, 10.3748/wjg.v18.i45.6635
- Atsasilp, (2016), Drug Metabolism and Pharmacokinetics, 31, pp. 90, 10.1016/j.dmpk.2015.12.004
- Sukasem, (2016), Journal of Clinical Laboratory Analysis, 30, pp. 84, 10.1002/jcla.21820
- Isaakidiou, (2016), Journal of Cancer Research and Therapeutics, 12, pp. 193, 10.4103/0973-1482.148654
- Zhang, (2016), Oncotargets and Therapy, 9, pp. 3335, 10.2147/OTT.S107190
- Li, (2017), Molecular Therapy – Nucleic Acids, 8, pp. 356, 10.1016/j.omtn.2017.07.007
- Zhou, (2015), Scientific Reports, 5, pp. 15972, 10.1038/srep15972
- Liu, (2017), Frontiers in Bioscience, 22, pp. 66, 10.2741/4472
- Wang, (2018), Lipids in Health and Disease, 17, pp. 75, 10.1186/s12944-018-0728-2
- Wang, (2017), BMC Cancer, 17, pp. 167, 10.1186/s12885-017-3151-6
- Qian, (2018), Biomedical and Enviromental Sciences, 7, pp. 525
- Tripathi, (2013), PLoS Genetics, 9, pp. e1003368, 10.1371/journal.pgen.1003368
- Mouradov, (2013), American Journal of Gastroenterology, 108, pp. 1785, 10.1038/ajg.2013.292
- Van Emburgh, (2016), Nature Communications, 7, pp. 13665, 10.1038/ncomms13665
- Ramirez, (2017), Journal of Oncology Pharmacy Practice, 23, pp. 226, 10.1177/1078155216634181